Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Alendronate Tablets Effective 05/21/2026 - 05/20/2027

36E79725R0069

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Marlex Pharmaceuticals Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of October 28, 2025.

N/A

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Marlex Pharmaceuticals Inc.
UEI
VSSNJEFMPLB3
CAGE
1TAP7
Vendor location
New Castle, DE
Contract
36E79726D0016
Obligated
$0.00, potential $4,350,222
Actions
1 between January 7, 2026 and January 7, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Alendronate Tablets with Marlex Pharmaceuticals, INC. Period of Performance Is 5/21/2026 - 5/20/2027.
Match
award number 36E79726D0016 equals the contract number; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 23, 2025

    Presolicitation

    Alendronate Tablets

    Due November 13, 2025 at 3:30 PM EST. SAM.gov, notice 6128e798cc0f401eb86a6ce445f1759d

  2. October 28, 2025

    Solicitation, originally presolicitation

    Alendronate Tablets

    Due November 13, 2025 at 3:30 PM EST. SAM.gov, notice 8b637a03c24e45588fc3c3e48ef0666e

  3. January 8, 2026

    Award notice, originally solicitation

    Awarded to Marlex Pharmaceuticals Inc. New Castle 19720 for $4,350,222. SAM.gov, notice f67282087e3a4972a647a3fac60994ea

Points of contact

Also open from this buyer